Centessa Pharmaceuticals's total assets for Q4 2025 were $687.50M, an increase of 53.36% from the previous quarter. CNTA total liabilities were $160.63M for the fiscal quarter, a 9.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.